FDA Orange Book · active-ingredient family
Promazine hydrochloride
Promazine hydrochloride is approved as 3 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:SPARINE · NDA 010942
3
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · concentrate, injectable, syrup, tablet
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PROMAZINE HYDROCHLORIDE | WATSON LABS | ANDA 084510 | — | Approved Prior to Jan 1, 1982 | |
| PROMAZINE HYDROCHLORIDE | WATSON LABS | ANDA 084517 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Promazine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

